{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:29:22Z","timestamp":1772634562140,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.taap.2021.115694","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T18:58:13Z","timestamp":1629572293000},"page":"115694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of the environmental contamination and exposure risk in medical\/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy"],"prefix":"10.1016","volume":"429","author":[{"given":"Marion","family":"Larroque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Arnaudguilhem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brice","family":"Bouyssiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Quenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabila","family":"Bouazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Jarlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Boulabas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Mounicou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Sgarbura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2021.115694_bb0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.talanta.2019.05.098","article-title":"Determination of Zn, Cu and Fe in human patients\u2019 serum using micro-sampling ICP-MS and sample dilution","volume":"204","author":"Abduljabbar","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.taap.2021.115694_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviscsurg.2020.02.005","article-title":"Non-medical caregivers and the use of intraperitoneal chemotherapy in the operating theatre: a survey on the perception of safety","author":"Al Hosni","year":"2020","journal-title":"J. Visceral Surg."},{"key":"10.1016\/j.taap.2021.115694_bb0015","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.taap.2021.115694_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2020.05.007","article-title":"Standardizing training for pressurized intraperitoneal aerosol chemotherapy","author":"Alyami","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.taap.2021.115694_bb0025","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ejso.2018.05.020","article-title":"Occupational exposure to cisplatin\/oxaliplatin during pressurized intraperitoneal aerosol chemotherapy (PIPAC)?","volume":"44","author":"Ametsbichler","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.taap.2021.115694_bb0030","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1039\/c2sc20627g","article-title":"Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry?","volume":"3","author":"Casini","year":"2012","journal-title":"Chem. Sci."},{"key":"10.1016\/j.taap.2021.115694_bb0035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11605-017-3565-0","article-title":"Pressurized Intraperitoneal aerosol chemotherapy (PIPAC) procedure for non-resectable peritoneal carcinomatosis (with video)","volume":"22","author":"Cazauran","year":"2018","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.taap.2021.115694_bb0040","author":"CDC"},{"key":"10.1016\/j.taap.2021.115694_bb0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrclinonc.2009.217","article-title":"Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence","volume":"7","author":"Ceelen","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.taap.2021.115694_bb0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00280-014-2525-6","article-title":"Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery","volume":"74","author":"Chalret du Rieu","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2021.115694_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.02.050","article-title":"Discrete sampling based-flow injection as an introduction system in ICP-MS for the direct analysis of low volume human serum samples","author":"Chantada-V\u00e1zquez","year":"2019","journal-title":"Talanta."},{"issue":"1","key":"10.1016\/j.taap.2021.115694_bb0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/pp-2020-0148","article-title":"Current practice and perceptions of safety protocols for the use of intraperitoneal chemotherapy in the operating room: results of the IP-OR international survey","volume":"6","author":"Clerc","year":"2021","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.taap.2021.115694_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviscsurg.2019.06.010","article-title":"Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow","author":"Delhorme","year":"2019","journal-title":"J. Visceral Surg."},{"key":"10.1016\/j.taap.2021.115694_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/codi.13130","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis","author":"Demtr\u00f6der","year":"2016","journal-title":"ColorectalDisease."},{"key":"10.1016\/j.taap.2021.115694_bb0075","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920940887","article-title":"Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma","author":"Di Giorgio","year":"2020","journal-title":"Therap. Adv. Med. Oncol."},{"key":"10.1016\/j.taap.2021.115694_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejca.2020.09.010","article-title":"A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers","volume":"140","author":"Dumont","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.taap.2021.115694_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijms.2017.10.001","article-title":"Determination of 21 elements in human serum using ICP-MS with collision\/reaction cell","author":"Gong","year":"2017","journal-title":"Int. J. Mass Spectrom."},{"issue":"4","key":"10.1016\/j.taap.2021.115694_bb0090","first-page":"1205","article-title":"Clinical pharmacokinetics of oxaliplatin: a critical review","volume":"6","author":"Graham","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2021.115694_bb0095","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2016-0019","article-title":"Environmental safety during the administration of pressurized IntraPeritoneal aerosol chemotherapy (PIPAC)","volume":"1","author":"Graversen","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.taap.2021.115694_bb0100","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ejso.2017.03.019","article-title":"Pressurized IntraPeritoneal aerosol chemotherapy \u2013 practical aspects","volume":"43","author":"H\u00fcbner","year":"2017","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"10.1016\/j.taap.2021.115694_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jso.21740","article-title":"Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure","volume":"103","author":"Konate","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.taap.2021.115694_bb0110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clinbiochem.2014.12.003","article-title":"Alkali dilution of blood samples for high throughput ICP-MS analysis\u2014comparison with acid digestion","volume":"48","author":"Lu","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.taap.2021.115694_bb0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.toxlet.2018.05.031","article-title":"Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination","volume":"298","author":"Ndaw","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2021.115694_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2019.05.007","article-title":"Oxaliplatin use in pressurized intraperitoneal aerosole chemotherapy(PIPAC) is safe and well tolerated: a multicenter study","volume":"45","author":"Sgarbura","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.taap.2021.115694_bb0125","article-title":"Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC)\u202f: still standardized or on the verge of diversification?","author":"Sgarbura","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.taap.2021.115694_bb0130","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","article-title":"Pressurized Intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects","volume":"20","author":"Sola\u00df","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.taap.2021.115694_bb0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.taap.2021.115694_bb0140","article-title":"Pressurized Intraperitoneal aerosol chemotherapy enhanced by electrostatic precipitation (ePIPAC) for patients with peritoneal metastases","author":"Taibi","year":"2020","journal-title":"Ann SurgOncol."},{"key":"10.1016\/j.taap.2021.115694_bb0145","first-page":"57","article-title":"Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents","volume":"134","author":"Turci","year":"2002","journal-title":"ToxicolLett"},{"issue":"1","key":"10.1016\/j.taap.2021.115694_bb0150","first-page":"28","article-title":"Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC)","volume":"53","author":"Villa","year":"2015","journal-title":"ND Health"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21002982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21002982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:55:15Z","timestamp":1758574515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21002982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":30,"alternative-id":["S0041008X21002982"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115694","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the environmental contamination and exposure risk in medical\/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115694"}}